Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Atrial fibrillation, is warfarin the only option for stroke prevention?

Khan M, Kamal AK.

J Pak Med Assoc. 2011 Mar;61(3):301-2. No abstract available.

2.

Clopidogrel plus aspirin vs oral anticoagulation for atrial fibrillation: the ACTIVE W trial.

DeSilvey DL.

Am J Geriatr Cardiol. 2006 Sep-Oct;15(5):326-7. No abstract available.

PMID:
16957455
3.

Atrial fibrillation, is warfarin the only option for stroke prevention?

Khan M, Kamal AK.

J Pak Med Assoc. 2011 Apr;61(4):406-7. No abstract available.

4.

The unmet need of patients with atrial fibrillation: AVERROES and the novel oral anticoagulants.

Hart RG.

Int J Stroke. 2011 Jun;6(3):207-8. doi: 10.1111/j.1747-4949.2011.00617.x. No abstract available.

PMID:
21557805
5.

Good old warfarin for stroke prevention in atrial fibrillation.

Verheugt FW.

Lancet. 2006 Jun 10;367(9526):1877-8. No abstract available. Erratum in: Lancet. 2006 Jun 24;367(9528):2060.

PMID:
16765740
6.

Prevention of stroke in patients with atrial fibrillation.

[No authors listed]

Med Lett Drugs Ther. 2009 Jun 1;51(1313):41. No abstract available.

PMID:
19478692
7.

[Preventing cerebrovascular accidents during atrial fibrillation].

Ederhy S, Meuleman C, Hammoudi N, Janower S, Boccara F, Cohen A.

Presse Med. 2005 Oct 22;34(18):1315-24. Review. French.

PMID:
16269996
8.
9.

Preventing stroke in patients with atrial fibrillation.

Edds W, Newton W.

J Fam Pract. 2000 Jan;49(1):8-9. No abstract available.

PMID:
10678330
10.

Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial.

ACTIVE Writing Group of the ACTIVE Investigators., Connolly S, Pogue J, Hart R, Pfeffer M, Hohnloser S, Chrolavicius S, Pfeffer M, Hohnloser S, Yusuf S.

Lancet. 2006 Jun 10;367(9526):1903-12.

PMID:
16765759
11.

Who is ineligible for warfarin in atrial fibrillation?

Verheugt FW.

Lancet. 2009 Aug 15;374(9689):510-1. doi: 10.1016/S0140-6736(09)61471-9. No abstract available. Erratum in: Lancet. 2009 Oct 3;374(9696):1148.

PMID:
19683630
12.

Trials of newer approaches to anticoagulation in atrial fibrillation.

Cooper HA.

J Interv Card Electrophysiol. 2004;10 Suppl 1:27-31. Review.

PMID:
14739737
13.

Underutilisation of Guideline-based Therapy Primary Prevention among Patients Presenting with AF-related Ischaemic Stroke.

Fabiaña N, Ramaswami AP, Ang ES, De Silva DA.

Ann Acad Med Singapore. 2015 Jul;44(7):266-8. No abstract available.

14.

Newer anticoagulants as an alternate to warfarin in atrial fibrillation: a changing paradigm.

Chaudhari D, Bhuriya R, Arora R.

Am J Ther. 2011 Jan;18(1):e1-e11. doi: 10.1097/MJT.0b013e3181d5ae5d. Review.

PMID:
20460986
15.

[The importance of oral anticoagulation in patients with atrial fibrillation for stroke prevention].

Neundörfer B.

Fortschr Neurol Psychiatr. 2008 Jul;76(7):383-4. doi: 10.1055/s-2008-1038167. German. No abstract available.

PMID:
18604771
16.

Rationale and design of ACTIVE: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events.

Active Steering Committee.; ACTIVE Investigators., Connolly S, Yusuf S, Budaj A, Camm J, Chrolavicius S, Commerford PJ, Flather M, Fox KA, Hart R, Hohnloser S, Joyner C, Pfeffer M, Anand I, Arthur H, Avezum A, Bethala-Sithya M, Blumenthal M, Ceremuzynski L, De Caterina R, Diaz R, Flaker G, Frangin G, Franzosi MG, Gaudin C, Golitsyn S, Goldhaber S, Granger C, Halon D, Hermosillo A, Hunt D, Jansky P, Karatzas N, Keltai M, Lanas F, Lau CP, Le Heuzey JY, Lewis BS, Morais J, Morillo C, Oto A, Paolasso E, Peters RJ, Pfisterer M, Piegas L, Pipillis T, Proste C, Sitkei E, Swedberg K, Synhorst D, Talajic M, Trégou V, Valentin V, van Mieghem W, Weintraub W, Varigos J.

Am Heart J. 2006 Jun;151(6):1187-93.

PMID:
16781218
17.

Does warfarin for stroke thromboprophylaxis protect against MI in atrial fibrillation patients?

Lip GY, Lane DA.

Am J Med. 2010 Sep;123(9):785-9. doi: 10.1016/j.amjmed.2010.01.031. Epub 2010 Jul 23. Review.

PMID:
20655037
18.

Clopidogrel-aspirin combination for atrial fibrillation: CLAAF is not CLEAR.

Jackson SL, Peterson GM, Bereznicki LR.

Am Heart J. 2005 Jan;149(1):e3; author reply e4. No abstract available.

PMID:
15660026
19.

[Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative].

Själander A, Wallentin L, Rosenqvist M, Svensson P.

Lakartidningen. 2008 Sep 10-16;105(37):2478-80. Swedish. No abstract available.

PMID:
19006862
20.

Atrial fibrillation and stroke risk prevention in real-life clinical practice.

Tay KH, Lip GY, Lane DA.

Thromb Haemost. 2009 Mar;101(3):415-6. No abstract available.

PMID:
19277398

Supplemental Content

Support Center